During the past decade, Wake Forest Institute for Regenerative Medicine (WFIRM) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Forest Institute for Regenerative Medicine (WFIRM)" #1 collaborator was "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Wake Forest Institute for Regenerative Medicine (WFIRM)" are "Male Urogenital Diseases" (1 trials), "Urethral Injury" (1 trials), "Urethral Stricture" (1 trials), "Urinary Incontinence" (1 trials) and "Urologic Diseases" (1 trials). Many other conditions were trialed in "Wake Forest Institute for Regenerative Medicine (WFIRM)" in a lesser frequency.

Most popular intervention types in "Wake Forest Institute for Regenerative Medicine (WFIRM)" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Autologous Engineered Urethral Construct" (1 trials) and "Autologous Muscle Progenitor Cells" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wake Forest Institute for Regenerative Medicine (WFIRM)" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Wake Forest Institute for Regenerative Medicine (WFIRM)". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wake Forest Institute for Regenerative Medicine (WFIRM), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wake Forest Institute for Regenerative Medicine (WFIRM), 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".